Literature DB >> 10216868

Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells.

E L Hartland1, M Batchelor, R M Delahay, C Hale, S Matthews, G Dougan, S Knutton, I Connerton, G Frankel.   

Abstract

Enteropathogenic Escherichia coli (EPEC) induce characteristic attaching and effacing (A/E) lesions on epithelial cells. This event is mediated, in part, by binding of the bacterial outer membrane protein, intimin, to a second EPEC protein, Tir (translocated intimin receptor), which is exported by the bacteria and integrated into the host cell plasma membrane. In this study, we have localized the intimin-binding domain of Tir to a central 107-amino-acid region, designated Tir-M. We provide evidence that both the amino- and carboxy-termini of Tir are located within the host cell. In addition, using immunogold labelling electron microscopy, we have confirmed that intimin can bind independently to host cells even in the absence of Tir. This Tir-independent interaction and the ability of EPEC to induce A/E lesions requires an intact lectin-like module residing at the carboxy-terminus of the intimin polypeptide. Using the yeast two-hybrid system and gel overlays, we show that intimin can bind both Tir and Tir-M even when the lectin-like domain is disrupted. These data provide strong evidence that intimin interacts not only with Tir but also in a lectin-like manner with a host cell intimin receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216868     DOI: 10.1046/j.1365-2958.1999.01338.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  73 in total

1.  Mechanical fractionation reveals structural requirements for enteropathogenic Escherichia coli Tir insertion into host membranes.

Authors:  A Gauthier; M de Grado; B B Finlay
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Enteropathogenic Escherichia coli (EPEC) Tir receptor molecule does not undergo full modification when introduced into host cells by EPEC-independent mechanisms.

Authors:  B Kenny; J Warawa
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Expression, purification, crystallization and crystallographic analysis of the N-terminal domain of translocated intimin receptor.

Authors:  Bing Yang Huang; Jiang Gu; Yan Fang Zhang; Jun Jun Zhou; Xiao Yong Song; Yi Lin; Xin Min Li; Lu Li
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-01-01       Impact factor: 1.056

4.  Interaction of enteropathogenic and Shiga toxin-producing Escherichia coli and porcine intestinal mucosa: role of intimin and Tir in adherence.

Authors:  Francis Girard; Isabelle Batisson; Gad M Frankel; Josée Harel; John M Fairbrother
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 5.  Adherence of diarrheagenic Escherichia coli strains to epithelial cells.

Authors:  Alfredo G Torres; Xin Zhou; James B Kaper
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions.

Authors:  Robert K Shaw; Jennifer Cleary; Michael S Murphy; Gad Frankel; Stuart Knutton
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

7.  The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).

Authors:  Nichollas E Scott; Cristina Giogha; Georgina L Pollock; Catherine L Kennedy; Andrew I Webb; Nicholas A Williamson; Jaclyn S Pearson; Elizabeth L Hartland
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

8.  Enteropathogenic Escherichia coli O125:H6 triggers attaching and effacing lesions on human intestinal biopsy specimens independently of Nck and TccP/TccP2.

Authors:  Li Bai; Stephanie Schüller; Andrew Whale; Aurelie Mousnier; Olivier Marches; Lei Wang; Tadasuke Ooka; Robert Heuschkel; Franco Torrente; James B Kaper; Tânia A T Gomes; Jianguo Xu; Alan D Phillips; Gad Frankel
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

9.  Differences in levels of secreted locus of enterocyte effacement proteins between human disease-associated and bovine Escherichia coli O157.

Authors:  A McNally; A J Roe; S Simpson; F M Thomson-Carter; D E Hoey; C Currie; T Chakraborty; D G Smith; D L Gally
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 10.  Exploitation of eukaryotic subcellular targeting mechanisms by bacterial effectors.

Authors:  Stuart W Hicks; Jorge E Galán
Journal:  Nat Rev Microbiol       Date:  2013-05       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.